Office of the Director, National Institutes of Health; Notice of Meeting, 76055 [2012-30900]
Download as PDF
Federal Register / Vol. 77, No. 247 / Wednesday, December 26, 2012 / Notices
Place: National Institutes of Health,
Building 31, 31 Center Drive, C Wing,
Conference Room 6, Bethesda, MD 20892.
Contact Person: Robin Barr, Ph.D.,
Director, National Institute on Aging, Office
of Extramural Activities, Gateway Building,
7201 Wisconsin Avenue, Bethesda, MD
20814, (301) 496–9322, barrr@nia.nih.gov.
Any interested person my file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedure for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit. Information is also available on the
Institute’s/Center’s home page: www.nih.gov/
nia/naca/, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: December 17, 2012.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–30898 Filed 12–21–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
tkelley on DSK3SPTVN1PROD with
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting hosted by the
NIH Scientific Management Review
Board (SMRB). Presentations and
discussions will address topics that
have been charged to the SMRB,
including the organization of substance
use, abuse, and addiction research
portfolios at NIH; ways to enhance the
NIH SBIR/STTR programs; and the
optimal approach to studying the value
of biomedical research conducted by
NIH.
The NIH Reform Act of 2006 (Public
Law 109–482) provides organizational
authorities to HHS and NIH officials to:
(1) Establish or abolish national research
institutes; (2) reorganize the offices
within the Office of the Director, NIH
including adding, removing, or
transferring the functions of such offices
or establishing or terminating such
VerDate Mar<15>2010
06:31 Dec 22, 2012
Jkt 229001
offices; and (3) reorganize, divisions,
centers, or other administrative units
within an NIH national research
institute or national center including
adding, removing, or transferring the
functions of such units, or establishing
or terminating such units. The purpose
of the SMRB is to advise appropriate
HHS and NIH officials on the use of
these organizational authorities and
identify the reasons underlying the
recommendations.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Scientific
Management Review Board (SMRB).
Date: January 14, 2013.
Time: 8:30 a.m. to 4:30 p.m.
Agenda: The meeting topics will include:
(1) A report from NIH on the organization of
its substance use, abuse, and addiction
research portfolio; (2) an update from the
SBIR/STTR Working Group; and (3)
presentations that explore approaches to
studying the value of biomedical research.
Time will be allotted on the agenda for
public comment. Sign up for public
comments will begin approximately at 8:00
a.m. on January 14, 2013, and will be
restricted to one sign-in per person. In the
event that time does not allow for all those
interested to present oral comments, any
interested person may file written comments
with the committee by forwarding the
statement to the Contact Person listed on this
notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Place: National Institutes of Health,
Building 31, C-Wing, 6th Floor, Conference
Room 10, 31 Center Drive, Bethesda, MD
20892.
Contact Person: Juanita Marner, Office of
Science Policy, Office of the Director, NIH,
National Institutes of Health, 6705 Rockledge
Drive, Suite 750, Bethesda, MD 20892,
smrb@mail.nih.gov. (301) 435–1770.
The meeting will also be webcast. The draft
meeting agenda and other information about
the SMRB, including information about
access to the webcast, will be available at
https://smrb.od.nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxis, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
PO 00000
Frm 00088
Fmt 4703
Sfmt 4703
76055
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: December 17, 2012.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–30900 Filed 12–21–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Biological Chemistry and
Macromolecular Biophysics.
Date: January 17–18, 2013.
Time: 11:00 a.m. to 10:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Donald L Schneider, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5160,
MSC 7842, Bethesda, MD 20892, (301) 435–
1727, schneidd@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflicts: Gastrointestinal Physiology/
Pathophysiology.
Date: January 23, 2013.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Atul Sahai, Ph.D.,
Scientific Review Officer, Center for
E:\FR\FM\26DEN1.SGM
26DEN1
Agencies
[Federal Register Volume 77, Number 247 (Wednesday, December 26, 2012)]
[Notices]
[Page 76055]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-30900]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting hosted by
the NIH Scientific Management Review Board (SMRB). Presentations and
discussions will address topics that have been charged to the SMRB,
including the organization of substance use, abuse, and addiction
research portfolios at NIH; ways to enhance the NIH SBIR/STTR programs;
and the optimal approach to studying the value of biomedical research
conducted by NIH.
The NIH Reform Act of 2006 (Public Law 109-482) provides
organizational authorities to HHS and NIH officials to: (1) Establish
or abolish national research institutes; (2) reorganize the offices
within the Office of the Director, NIH including adding, removing, or
transferring the functions of such offices or establishing or
terminating such offices; and (3) reorganize, divisions, centers, or
other administrative units within an NIH national research institute or
national center including adding, removing, or transferring the
functions of such units, or establishing or terminating such units. The
purpose of the SMRB is to advise appropriate HHS and NIH officials on
the use of these organizational authorities and identify the reasons
underlying the recommendations.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Scientific Management Review Board (SMRB).
Date: January 14, 2013.
Time: 8:30 a.m. to 4:30 p.m.
Agenda: The meeting topics will include: (1) A report from NIH
on the organization of its substance use, abuse, and addiction
research portfolio; (2) an update from the SBIR/STTR Working Group;
and (3) presentations that explore approaches to studying the value
of biomedical research. Time will be allotted on the agenda for
public comment. Sign up for public comments will begin approximately
at 8:00 a.m. on January 14, 2013, and will be restricted to one
sign-in per person. In the event that time does not allow for all
those interested to present oral comments, any interested person may
file written comments with the committee by forwarding the statement
to the Contact Person listed on this notice. The statement should
include the name, address, telephone number and when applicable, the
business or professional affiliation of the interested person.
Place: National Institutes of Health, Building 31, C-Wing, 6th
Floor, Conference Room 10, 31 Center Drive, Bethesda, MD 20892.
Contact Person: Juanita Marner, Office of Science Policy, Office
of the Director, NIH, National Institutes of Health, 6705 Rockledge
Drive, Suite 750, Bethesda, MD 20892, smrb@mail.nih.gov. (301) 435-
1770.
The meeting will also be webcast. The draft meeting agenda and
other information about the SMRB, including information about access
to the webcast, will be available at https://smrb.od.nih.gov.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxis, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: December 17, 2012.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-30900 Filed 12-21-12; 8:45 am]
BILLING CODE 4140-01-P